Nanexa AB (publ) (STO:NANEXA)
Sweden · Delayed Price · Currency is SEK 5.93
+0.43 (7.82%)
Sep 24, 2026, 5:29 PM CET
Nanexa AB Market Cap
Nanexa AB has a market cap or net worth of 1.13 billion as of September 24, 2026. Its market cap has increased by 217.31% in one year.
Market Cap
1.13B
Enterprise Value
1.08B
Revenue
33.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.93
ChartMarket Cap Chart
Since June 17, 2015, Nanexa AB's market cap has increased from 49.07M to 1.13B, an increase of 2,208.48%. That is a compound annual growth rate of 32.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.13B | 60.44% |
| Dec 30, 2025 | 706.11M | 140.91% |
| Dec 30, 2024 | 293.10M | 292.61% |
| Dec 29, 2023 | 74.66M | -46.84% |
| Dec 30, 2022 | 140.43M | -30.75% |
| Dec 30, 2021 | 202.78M | -19.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.09B |
| Cereno Scientific AB | 1.35B |
| Dicot Pharma AB | 783.92M |
| EQL Pharma AB | 690.99M |
| Cinclus Pharma Holding AB | 551.01M |
| Moberg Pharma AB | 518.99M |
| Orexo AB | 443.50M |
| Enzymatica AB | 411.44M |